<section xmlns="http://xml.house.gov/schemas/uslm/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" style="-uslm-lc:I80" id="ida4bdc725-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t"><num value="285t">§ 285t.</num><heading> Purpose of Institute</heading><subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4bdc726-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/a"><num value="a" class="bold">(a)</num><heading class="bold"> In general</heading><content><p style="-uslm-lc:I11" class="indent0">The general purpose of the National Institute on Minority Health and Health Disparities (in this subpart referred to as the “Institute”) is the conduct and support of research, training, dissemination of information, and other programs with respect to minority health conditions and other populations with health disparities.</p>
</content>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4bdc727-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/b"><num value="b" class="bold">(b)</num><heading class="bold"> Priorities</heading><content><p style="-uslm-lc:I11" class="indent0">The Director of the Institute shall in expending amounts appropriated under this subpart give priority to conducting and supporting minority health disparities research.</p>
</content>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4bdc728-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/c"><num value="c" class="bold">(c)</num><heading class="bold"> Minority health disparities research</heading><chapeau style="-uslm-lc:I11" class="indent0">For purposes of this subpart:</chapeau><paragraph style="-uslm-lc:I12" class="indent1" id="ida4bdc729-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/c/1"><num value="1">(1)</num><content> The term “minority health disparities research” means basic, clinical, and behavioral research on minority health conditions (as defined in paragraph (2)), including research to prevent, diagnose, and treat such conditions.</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="ida4bdc72a-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/c/2"><num value="2">(2)</num><chapeau> The term “minority health conditions”, with respect to individuals who are members of minority groups, means all diseases, disorders, and conditions (including with respect to mental health and substance abuse)—</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="ida4bdee3b-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/c/2/A"><num value="A">(A)</num><content> unique to, more serious, or more prevalent in such individuals;</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4bdee3c-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/c/2/B"><num value="B">(B)</num><content> for which the factors of medical risk or types of medical intervention may be different for such individuals, or for which it is unknown whether such factors or types are different for such individuals; or</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4bdee3d-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/c/2/C"><num value="C">(C)</num><content> with respect to which there has been insufficient research involving such individuals as subjects or insufficient data on such individuals.</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="ida4bdee3e-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/c/3"><num value="3">(3)</num><content> The term “minority group” has the meaning given the term “racial and ethnic minority group” in <ref href="/us/usc/t42/s300u–6">section 300u–6 of this title</ref>.</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="ida4bdee3f-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/c/4"><num value="4">(4)</num><content> The terms “minority” and “minorities” refer to individuals from a minority group.</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4bdee40-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/d"><num value="d" class="bold">(d)</num><heading class="bold"> Health disparity populations</heading><chapeau style="-uslm-lc:I11" class="indent0">For purposes of this subpart:</chapeau><paragraph style="-uslm-lc:I12" class="indent1" id="ida4bdee41-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/d/1"><num value="1">(1)</num><content> A population is a health disparity population if, as determined by the Director of the Institute after consultation with the Director of the Agency for Healthcare Research and Quality, there is a significant disparity in the overall rate of disease incidence, prevalence, morbidity, mortality, or survival rates in the population as compared to the health status of the general population.</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="ida4bdee42-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/d/2"><num value="2">(2)</num><content> The Director shall give priority consideration to determining whether minority groups qualify as health disparity populations under paragraph (1).</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="ida4bdee43-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/d/3"><num value="3">(3)</num><content> The term “health disparities research” means basic, clinical, and behavioral research on health disparity populations (including individual members and communities of such populations) that relates to health disparities as defined under paragraph (1), including the causes of such disparities and methods to prevent, diagnose, and treat such disparities.</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4bdee44-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/e"><num value="e" class="bold">(e)</num><heading class="bold"> Coordination of activities</heading><chapeau style="-uslm-lc:I11" class="indent0">The Director of the Institute shall act as the primary Federal official with responsibility for coordinating all minority health disparities research and other health disparities research conducted or supported by the National Institutes of Health, and—</chapeau><paragraph style="-uslm-lc:I12" class="indent1" id="ida4bdee45-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/e/1"><num value="1">(1)</num><content> shall represent the health disparities research program of the National Institutes of Health, including the minority health disparities research program, at all relevant Executive branch task forces, committees and planning activities; and</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="ida4bdee46-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/e/2"><num value="2">(2)</num><content> shall maintain communications with all relevant Public Health Service agencies, including the Indian Health Service, and various other departments of the Federal Government to ensure the timely transmission of information concerning advances in minority health disparities research and other health disparities research between these various agencies for dissemination to affected communities and health care providers.</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4bdee47-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f"><num value="f" class="bold">(f)</num><heading class="bold"> Collaborative comprehensive plan and budget</heading><paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4bdee48-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/1"><num value="1" class="bold">(1)</num><heading class="bold"> In general</heading><chapeau style="-uslm-lc:I12" class="indent1">Subject to the provisions of this section and other applicable law, the Director of NIH, the Director of the Institute, and the directors of the other agencies of the National Institutes of Health in collaboration (and in consultation with the advisory council for the Institute) shall—</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="ida4bdee49-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/1/A"><num value="A">(A)</num><content> establish a comprehensive plan and budget for the conduct and support of all minority health disparities research and other health disparities research activities of the agencies of the National Institutes of Health (which plan and budget shall be first established under this subsection not later than 12 months after <date date="2000-11-22">November 22, 2000</date>);</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be155a-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/1/B"><num value="B">(B)</num><content> ensure that the plan and budget establish priorities among the health disparities research activities that such agencies are authorized to carry out;</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be155b-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/1/C"><num value="C">(C)</num><content> ensure that the plan and budget establish objectives regarding such activities, describes the means for achieving the objectives, and designates the date by which the objectives are expected to be achieved;</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be155c-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/1/D"><num value="D">(D)</num><content> ensure that, with respect to amounts appropriated for activities of the Institute, the plan and budget give priority in the expenditure of funds to conducting and supporting minority health disparities research;</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be155d-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/1/E"><num value="E">(E)</num><content> ensure that all amounts appropriated for such activities are expended in accordance with the plan and budget;</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be155e-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/1/F"><num value="F">(F)</num><content> review the plan and budget not less than annually, and revise the plan and budget as appropriate;</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be155f-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/1/G"><num value="G">(G)</num><content> ensure that the plan and budget serve as a broad, binding statement of policies regarding minority health disparities research and other health disparities research activities of the agencies, but do not remove the responsibility of the heads of the agencies for the approval of specific programs or projects, or for other details of the daily administration of such activities, in accordance with the plan and budget; and</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be1560-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/1/H"><num value="H">(H)</num><content> promote coordination and collaboration among the agencies conducting or supporting minority health or other health disparities research.</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4be1561-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/2"><num value="2" class="bold">(2)</num><heading class="bold"> Certain components of plan and budget</heading><chapeau style="-uslm-lc:I12" class="indent1">With respect to health disparities research activities of the agencies of the National Institutes of Health, the Director of the Institute shall ensure that the plan and budget under paragraph (1) provide for—</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be1562-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/2/A"><num value="A">(A)</num><content> basic research and applied research, including research and development with respect to products;</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be1563-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/2/B"><num value="B">(B)</num><content> research that is conducted by the agencies;</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be1564-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/2/C"><num value="C">(C)</num><content> research that is supported by the agencies;</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be1565-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/2/D"><num value="D">(D)</num><content> proposals developed pursuant to solicitations by the agencies and for proposals developed independently of such solicitations; and</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be1566-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/2/E"><num value="E">(E)</num><content> behavioral research and social sciences research, which may include cultural and linguistic research in each of the agencies.</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4be1567-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/f/3"><num value="3" class="bold">(3)</num><heading class="bold"> Minority health disparities research</heading><content><p style="-uslm-lc:I12" class="indent1">The plan and budget under paragraph (1) shall include a separate statement of the plan and budget for minority health disparities research.</p>
</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4be1568-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/g"><num value="g" class="bold">(g)</num><heading class="bold"> Participation in clinical research</heading><content><p style="-uslm-lc:I11" class="indent0">The Director of the Institute shall work with the Director of NIH and the directors of the agencies of the National Institutes of Health to carry out the provisions of <ref href="/us/usc/t42/s289a–2">section 289a–2 of this title</ref> that relate to minority groups.</p>
</content>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4be1569-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/h"><num value="h" class="bold">(h)</num><heading class="bold"> Research endowments</heading><paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4be156a-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/h/1"><num value="1" class="bold">(1)</num><heading class="bold"> In general</heading><chapeau style="-uslm-lc:I12" class="indent1">The Director of the Institute may carry out a program to facilitate minority health disparities research and other health disparities research by providing for research endowments—</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be156b-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/h/1/1"><num value="1">(1)</num><content> <ref class="footnoteRef" idref="fn002192">1</ref><note type="footnote" id="fn002192"><num>1</num> So in original. Probably should be “(A)”.</note> at centers of excellence under <ref href="/us/usc/t42/s293">section 293 of this title</ref>; and</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be156c-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/h/1/2"><num value="2">(2)</num><content> <ref class="footnoteRef" idref="fn002193">2</ref><note type="footnote" id="fn002193"><num>2</num> So in original. Probably should be “(B)”.</note> at centers of excellence under <ref href="/us/usc/t42/s285t–1">section 285t–1 of this title</ref>.</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4be156d-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/h/2"><num value="2" class="bold">(2)</num><heading class="bold"> Eligibility</heading><chapeau style="-uslm-lc:I12" class="indent1">The Director of the Institute may provide for a research endowment under paragraph (1) only if the institution involved meets the following conditions:</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be156e-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/h/2/A"><num value="A">(A)</num><content> The institution does not have an endowment that is worth in excess of an amount equal to 50 percent of the national median of endowment funds at institutions that conduct similar biomedical research or training of health professionals.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4be3c7f-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/h/2/B"><num value="B">(B)</num><content> The application of the institution under paragraph (1) regarding a research endowment has been recommended pursuant to technical and scientific peer review and has been approved by the advisory council under subsection (j).</content>
</subparagraph>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4be3c80-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/i"><num value="i" class="bold">(i)</num><heading class="bold"> Certain activities</heading><chapeau style="-uslm-lc:I11" class="indent0">In carrying out subsection (a), the Director of the Institute—</chapeau><paragraph style="-uslm-lc:I12" class="indent1" id="ida4be3c81-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/i/1"><num value="1">(1)</num><content> shall assist the Director of NIH in carrying out <ref href="/us/usc/t42/s283k/c/2">section 283k(c)(2) of this title</ref> and in committing resources for construction at Institutions of Emerging Excellence under such section;</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="ida4be3c82-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/i/2"><num value="2">(2)</num><content> shall establish projects to promote cooperation among Federal agencies, State, local, tribal, and regional public health agencies, and private entities in health disparities research; and</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="ida4be3c83-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/i/3"><num value="3">(3)</num><content> may utilize information from previous health initiatives concerning minorities and other health disparity populations.</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4be3c84-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/j"><num value="j" class="bold">(j)</num><heading class="bold"> Advisory council</heading><paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4be3c85-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/j/1"><num value="1" class="bold">(1)</num><heading class="bold"> In general</heading><content><p style="-uslm-lc:I12" class="indent1">The Secretary shall, in accordance with <ref href="/us/usc/t42/s284a">section 284a of this title</ref>, establish an advisory council to advise, assist, consult with, and make recommendations to the Director of the Institute on matters relating to the activities described in subsection (a), and with respect to such activities to carry out any other functions described in <ref href="/us/usc/t42/s284a">section 284a of this title</ref> for advisory councils under such section. Functions under the preceding sentence shall include making recommendations on budgetary allocations made in the plan under subsection (f), and shall include reviewing reports under subsection (k) before the reports are submitted under such subsection.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4be3c86-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/j/2"><num value="2" class="bold">(2)</num><heading class="bold"> Membership</heading><content><p style="-uslm-lc:I12" class="indent1">With respect to the membership of the advisory council under paragraph (1), a majority of the members shall be individuals with demonstrated expertise regarding minority health disparity and other health disparity issues; representatives of communities impacted by minority and other health disparities shall be included; and a diversity of health professionals shall be represented. The membership shall in addition include a representative of the Office of Behavioral and Social Sciences Research under <ref href="/us/usc/t42/s283c">section 283c of this title</ref>.</p>
</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4be3c87-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s285t/k"><num value="k" class="bold">(k)</num><heading class="bold"> Intra-National Institutes of Health coordination</heading><content><p style="-uslm-lc:I11" class="indent0">The Director of the Institute, as the primary Federal official with responsibility for coordinating all research and activities conducted or supported by the National Institutes of Health on minority health and health disparities, shall plan, coordinate, review, and evaluate research and other activities conducted or supported by the national research institutes and national centers. The Director of the Institute may foster partnerships between the national research institutes and national centers and may encourage the funding of collaborative research projects to achieve the goals of the National Institutes of Health that are related to minority health and health disparities.</p>
</content>
</subsection>
<sourceCredit id="ida4be3c88-09a0-11eb-a85b-f5cef3d06f4d">(<ref href="/us/act/1944-07-01/ch373">July 1, 1944, ch. 373</ref>, title IV, § 464z–3, formerly § 485E, as added <ref href="/us/pl/106/525/tI/s101/a">Pub. L. 106–525, title I, § 101(a)</ref>, <date date="2000-11-22">Nov. 22, 2000</date>, <ref href="/us/stat/114/2497">114 Stat. 2497</ref>; amended <ref href="/us/pl/109/482/tI">Pub. L. 109–482, title I</ref>, §§ 103(b)(44), 104(b)(1)(N), <date date="2007-01-15">Jan. 15, 2007</date>, <ref href="/us/stat/120/3688">120 Stat. 3688</ref>, 3693; renumbered § 464z–3 and amended <ref href="/us/pl/111/148/tX/s10334/c/1/D">Pub. L. 111–148, title X, § 10334(c)(1)(D)</ref>, (2), <date date="2010-03-23">Mar. 23, 2010</date>, <ref href="/us/stat/124/973">124 Stat. 973</ref>; <ref href="/us/pl/112/74/dF/tII/s221/d/3">Pub. L. 112–74, div. F, title II, § 221(d)(3)</ref>, <date date="2011-12-23">Dec. 23, 2011</date>, <ref href="/us/stat/125/1090">125 Stat. 1090</ref>; <ref href="/us/pl/114/255/dA/tII/s2038/f">Pub. L. 114–255, div. A, title II, § 2038(f)</ref>, <date date="2016-12-13">Dec. 13, 2016</date>, <ref href="/us/stat/130/1066">130 Stat. 1066</ref>.)</sourceCredit>
<notes type="uscNote" id="ida4be6399-09a0-11eb-a85b-f5cef3d06f4d">
<note style="-uslm-lc:I76" topic="codification" id="ida4be639a-09a0-11eb-a85b-f5cef3d06f4d"><heading class="centered smallCaps">Codification</heading>
<p style="-uslm-lc:I21" class="indent0">Section was formerly classified to <ref href="/us/usc/t42/s287c–31">section 287c–31 of this title</ref> prior to renumbering by <ref href="/us/pl/111/148">Pub. L. 111–148</ref>.</p>
</note>
<note style="-uslm-lc:I74" topic="amendments" id="ida4be639b-09a0-11eb-a85b-f5cef3d06f4d"><heading class="centered smallCaps">Amendments</heading><p style="-uslm-lc:I21" class="indent0">2016—Subsec. (h). <ref href="/us/pl/114/255/s2038/f/1">Pub. L. 114–255, § 2038(f)(1)</ref>, redesignated subsec. (h) relating to interagency coordination as (k).</p>
<p style="-uslm-lc:I21" class="indent0">Subsec. (k). <ref href="/us/pl/114/255">Pub. L. 114–255</ref> redesignated subsec. (h) relating to interagency coordination as (k), in heading substituted “Intra-National Institutes of Health” for “Interagency”, in text substituted “as the primary Federal official” for “as the primary Federal officials” and “national research institutes and national centers” for “Institutes and Centers of the National Institutes of Health”, inserted a comma after “review”, and inserted at end “The Director of the Institute may foster partnerships between the national research institutes and national centers and may encourage the funding of collaborative research projects to achieve the goals of the National Institutes of Health that are related to minority health and health disparities.”</p>
<p style="-uslm-lc:I21" class="indent0">2011—Subsec. (i)(1). <ref href="/us/pl/112/74">Pub. L. 112–74</ref> substituted “Director of NIH” for “Director of the National Institute for Research Resources” and “283k(c)(2)” for “287a–1(c)(3)” and inserted “under such section” after “Institutions of Emerging Excellence”.</p>
<p style="-uslm-lc:I21" class="indent0">2010—<ref href="/us/pl/111/148/s10334/c/1/D/iii">Pub. L. 111–148, § 10334(c)(1)(D)(iii)</ref>, substituted “Institute” for “Center” in section catchline.</p>
<p style="-uslm-lc:I21" class="indent0">Subsec. (a). <ref href="/us/pl/111/148/s10334/c/1/D/ii">Pub. L. 111–148, § 10334(c)(1)(D)(ii)</ref>, (iii), substituted “National Institute on Minority Health and Health Disparities” for “National Center on Minority Health and Health Disparities” and “Institute” for “Center”.</p>
<p style="-uslm-lc:I21" class="indent0">Subsecs. (b), (d) to (g). <ref href="/us/pl/111/148/s10334/c/1/D/iii">Pub. L. 111–148, § 10334(c)(1)(D)(iii)</ref>, substituted “Institute” for “Center” wherever appearing.</p>
<p style="-uslm-lc:I21" class="indent0">Subsec. (h). <ref href="/us/pl/111/148/s10334/c/2/C">Pub. L. 111–148, § 10334(c)(2)(C)</ref>, added at end subsec. (h) relating to interagency coordination.</p>
<p style="-uslm-lc:I21" class="indent0">Subsec. (h)(1). <ref href="/us/pl/111/148/s10334/c/2/A">Pub. L. 111–148, § 10334(c)(2)(A)</ref>, in par. (1) of subsec. (h) relating to research endowments, substituted “research endowments—</p>
<p style="-uslm-lc:I22" class="indent1">“(1) at centers of excellence under <ref href="/us/usc/t42/s293">section 293 of this title</ref>; and</p>
<p style="-uslm-lc:I22" class="indent1">“(2) at centers of excellence under <ref href="/us/usc/t42/s285t–1">section 285t–1 of this title</ref>.”</p>
<p style="-uslm-lc:I33" class="indent0 firstIndent0">for “research endowments at centers of excellence under <ref href="/us/usc/t42/s293">section 293 of this title</ref>.”</p>
<p style="-uslm-lc:I21" class="indent0"><ref href="/us/pl/111/148/s10334/c/1/D/iii">Pub. L. 111–148, § 10334(c)(1)(D)(iii)</ref>, in par. (1) of subsec. (h) relating to research endowments, substituted “Institute” for “Center”.</p>
<p style="-uslm-lc:I21" class="indent0">Subsec. (h)(2). <ref href="/us/pl/111/148/s10334/c/1/D/iii">Pub. L. 111–148, § 10334(c)(1)(D)(iii)</ref>, in par. (2) of subsec. (h) relating to research endowments, substituted “Institute” for “Center” in introductory provisions.</p>
<p style="-uslm-lc:I21" class="indent0">Subsec. (h)(2)(A). <ref href="/us/pl/111/148/s10334/c/2/B">Pub. L. 111–148, § 10334(c)(2)(B)</ref>, in par. (2)(A) of subsec. (h) relating to research endowments, substituted “median” for “average”.</p>
<p style="-uslm-lc:I21" class="indent0">Subsecs. (i), (j). <ref href="/us/pl/111/148/s10334/c/1/D/iii">Pub. L. 111–148, § 10334(c)(1)(D)(iii)</ref>, substituted “Institute” for “Center” wherever appearing.</p>
<p style="-uslm-lc:I21" class="indent0">2007—Subsec. (k). <ref href="/us/pl/109/482/s104/b/1/N">Pub. L. 109–482, § 104(b)(1)(N)</ref>, struck out heading and text of subsec. (k). Text read as follows: “The Director of the Center shall prepare an annual report on the activities carried out or to be carried out by the Center, and shall submit each such report to the Committee on Health, Education, Labor, and Pensions of the Senate, the Committee on Commerce of the House of Representatives, the Secretary, and the Director of NIH. With respect to the fiscal year involved, the report shall—</p>
<p style="-uslm-lc:I22" class="indent1">“(1) describe and evaluate the progress made in health disparities research conducted or supported by the national research institutes;</p>
<p style="-uslm-lc:I22" class="indent1">“(2) summarize and analyze expenditures made for activities with respect to health disparities research conducted or supported by the National Institutes of Health;</p>
<p style="-uslm-lc:I22" class="indent1">“(3) include a separate statement applying the requirements of paragraphs (1) and (2) specifically to minority health disparities research; and</p>
<p style="-uslm-lc:I22" class="indent1">“(4) contain such recommendations as the Director considers appropriate.”</p>
<p style="-uslm-lc:I21" class="indent0">Subsec. (<i>l</i>). <ref href="/us/pl/109/482/s103/b/44">Pub. L. 109–482, § 103(b)(44)</ref>, struck out heading and text of subsec. (<i>l</i>). Text read as follows: “For the purpose of carrying out this subpart, there are authorized to be appropriated $100,000,000 for fiscal year 2001, and such sums as may be necessary for each of the fiscal years 2002 through 2005. Such authorization of appropriations is in addition to other authorizations of appropriations that are available for the conduct and support of minority health disparities research or other health disparities research by the agencies of the National Institutes of Health.”</p>
</note>
<note style="-uslm-lc:I74" topic="effectiveDateOfAmendment" id="ida4be8aac-09a0-11eb-a85b-f5cef3d06f4d"><heading class="centered smallCaps">Effective Date of 2007 Amendment</heading><p style="-uslm-lc:I21" class="indent0">Amendment by <ref href="/us/pl/109/482">Pub. L. 109–482</ref> applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see <ref href="/us/pl/109/482/s109">section 109 of Pub. L. 109–482</ref>, set out as a note under <ref href="/us/usc/t42/s281">section 281 of this title</ref>.</p>
</note>
<note style="-uslm-lc:I74" topic="miscellaneous" id="ida4be8aad-09a0-11eb-a85b-f5cef3d06f4d"><heading class="centered smallCaps">Findings</heading><p><ref href="/us/pl/106/525/s2">Pub. L. 106–525, § 2</ref>, <date date="2000-11-22">Nov. 22, 2000</date>, <ref href="/us/stat/114/2495">114 Stat. 2495</ref>, provided that: <quotedContent origin="/us/pl/106/525/s2">
<inline>“The Congress finds as follows:</inline>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="1">“(1)</num><content> Despite notable progress in the overall health of the Nation, there are continuing disparities in the burden of illness and death experienced by African Americans, Hispanics, Native Americans, Alaska Natives, and Asian Pacific Islanders, compared to the United States population as a whole.</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="2">“(2)</num><content> The largest numbers of the medically underserved are white individuals, and many of them have the same health care access problems as do members of minority groups. Nearly 20,000,000 white individuals live below the poverty line with many living in nonmetropolitan, rural areas such as Appalachia, where the high percentage of counties designated as health professional shortage areas (47 percent) and the high rate of poverty contribute to disparity outcomes. However, there is a higher proportion of racial and ethnic minorities in the United States represented among the medically underserved.</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="3">“(3)</num><content> There is a national need for minority scientists in the fields of biomedical, clinical, behavioral, and health services research. Ninety percent of minority physicians educated at Historically Black Medical Colleges live and serve in minority communities.</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="4">“(4)</num><content> Demographic trends inspire concern about the Nation’s ability to meet its future scientific, technological, and engineering workforce needs. Historically, non-Hispanic white males have made up the majority of the United States scientific, technological, and engineering workers.</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="5">“(5)</num><content> The Hispanic and Black population will increase significantly in the next 50 years. The scientific, technological, and engineering workforce may decrease if participation by underrepresented minorities remains the same.</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="6">“(6)</num><content> Increasing rates of Black and Hispanic workers can help ensure a strong scientific, technological, and engineering workforce.</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="7">“(7)</num><content> Individuals such as underrepresented minorities and women in the scientific, technological, and engineering workforce enable society to address its diverse needs.</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="8">“(8)</num><content> If there had not been a substantial increase in the number of science and engineering degrees awarded to women and underrepresented minorities over the past few decades, the United States would be facing even greater shortages in scientific, technological, and engineering workers.</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="9">“(9)</num><content> In order to effectively promote a diverse and strong 21st century scientific, technological, and engineering workforce, Federal agencies should expand or add programs that effectively overcome barriers such as educational transition from one level to the next and student requirements for financial resources.</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="10">“(10)</num><content> Federal agencies should work in concert with the private nonprofit sector to emphasize the recruitment and retention of qualified individuals from ethnic and gender groups that are currently underrepresented in the scientific, technological, and engineering workforce.</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="11">“(11)</num><content> Behavioral and social sciences research has increased awareness and understanding of factors associated with health care utilization and access, patient attitudes toward health services, and risk and protective behaviors that affect health and illness. These factors have the potential to then be modified to help close the health disparities gap among ethnic minority populations. In addition, there is a shortage of minority behavioral science researchers and behavioral health care professionals. According to the National Science Foundation, only 15.5 percent of behavioral research-oriented psychology doctorate degrees were awarded to minority students in 1997. In addition, only 17.9 percent of practice-oriented psychology doctorate degrees were awarded to ethnic minorities.”</content>
</paragraph>
</quotedContent>
</p>
</note>
<note style="-uslm-lc:I74" topic="miscellaneous" id="ida4beb1be-09a0-11eb-a85b-f5cef3d06f4d"><heading class="centered smallCaps">Public Awareness and Dissemination of Information on Health Disparities</heading><p><ref href="/us/pl/106/525/tV/s501">Pub. L. 106–525, title V, § 501</ref>, <date date="2000-11-22">Nov. 22, 2000</date>, <ref href="/us/stat/114/2510">114 Stat. 2510</ref>, provided that:<quotedContent origin="/us/pl/106/525/tV/s501">
<subsection style="-uslm-lc:I21" class="indent0"><num value="a">“(a)</num><heading> <inline class="small-caps">Public Awareness on Health Disparities</inline>.—</heading><chapeau>The Secretary of Health and Human Services (in this section referred to as the ‘Secretary’) shall conduct a national campaign to inform the public and health care professionals about health disparities in minority and other underserved populations by disseminating information and materials available on specific diseases affecting these populations and programs and activities to address these disparities. The campaign shall—</chapeau><paragraph style="-uslm-lc:I22" class="indent1"><num value="1">“(1)</num><content> have a specific focus on minority and other underserved communities with health disparities; and</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="2">“(2)</num><content> include an evaluation component to assess the impact of the national campaign in raising awareness of health disparities and information on available resources.</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I21" class="indent0"><num value="b">“(b)</num><heading> <inline class="small-caps">Dissemination of Information on Health Disparities</inline>.—</heading><chapeau>The Secretary shall develop and implement a plan for the dissemination of information and findings with respect to health disparities under titles I, II, III, and IV of this Act [see Tables for classification]. The plan shall—</chapeau><paragraph style="-uslm-lc:I22" class="indent1"><num value="1">“(1)</num><content> include the participation of all agencies of the Department of Health and Human Services that are responsible for serving populations included in the health disparities research; and</content>
</paragraph>
<paragraph style="-uslm-lc:I22" class="indent1"><num value="2">“(2)</num><content> have agency-specific strategies for disseminating relevant findings and information on health disparities and improving health care services to affected communities.”</content>
</paragraph>
</subsection>
</quotedContent>
</p>
</note>
<note style="-uslm-lc:I74" topic="miscellaneous" id="ida4beb1bf-09a0-11eb-a85b-f5cef3d06f4d"><heading class="centered smallCaps">Termination of Advisory Councils</heading><p style="-uslm-lc:I21" class="indent0">Advisory councils established after <date date="1973-01-05">Jan. 5, 1973</date>, to terminate not later than the expiration of the 2-year period beginning on the date of their establishment, unless, in the case of a council established by the President or an officer of the Federal Government, such council is renewed by appropriate action prior to the expiration of such 2-year period, or in the case of a council established by Congress, its duration is otherwise provided by law. See sections 3(2) and 14 of <ref href="/us/pl/92/463">Pub. L. 92–463</ref>, <date date="1972-10-06">Oct. 6, 1972</date>, <ref href="/us/stat/86/770">86 Stat. 770</ref>, 776, set out in the Appendix to Title 5, Government Organization and Employees.</p>
<p style="-uslm-lc:I21" class="indent0"><ref href="/us/pl/93/641/s6">Pub. L. 93–641, § 6</ref>, <date date="1975-01-04">Jan. 4, 1975</date>, <ref href="/us/stat/88/2275">88 Stat. 2275</ref>, set out as a note under <ref href="/us/usc/t42/s217a">section 217a of this title</ref>, provided that an advisory committee established pursuant to the Public Health Service Act shall terminate at such time as may be specifically prescribed by an Act of Congress enacted after <date date="1975-01-04">Jan. 4, 1975</date>.</p>
</note>
</notes>
</section>